108 results on '"Novocure"'
Search Results
2. HUMC 1612: Optune NovoTTF-200A System
3. Optune for Children With High-Grade Glioma or Ependymoma, and Optune With Radiation Therapy for Children With DIPG
4. Nivolumab in Combination With Chemotherapy Pre-Surgery in Treating Patients With Borderline Resectable Pancreatic Cancer
5. Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-100M for the Treatment of Melanoma Brain Metastases
6. Tryptophan Metabolism in Human Brain Tumors
7. Study Testing The Safety and Efficacy of Adjuvant Temozolomide Plus TTFields (Optune®) Plus Pembrolizumab in Patients With Newly Diagnosed Glioblastoma (2-THE-TOP) (2-THE-TOP)
8. NovoTTF-200A + Pembrolizumab In Melanoma Brain Metastasis
9. Temozolomide, Radiation Therapy, and Tumor Treating Fields Therapy in Treating Participants With Glioblastoma
10. Study of Biologic Tumor and Plasma Biomarkers of Response to TTFields in Patients Treated for Newly Diagnosed Glioblastoma (EXOFIELDS)
11. Stereotactic Body Radiation and Tumor Treating Fields for Locally Advanced Pancreas Cancer
12. Safety and Immunogenicity of Personalized Genomic Vaccine and Tumor Treating Fields (TTFields) to Treat Glioblastoma
13. Tumor Treating Fields With Chemoradiation in Newly Diagnosed GBM
14. Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed Glioblastoma
15. Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC
16. Niraparib/TTFields in GBM
17. WBSI Guided Personalized Delivery of TTFields
18. Preoperative Preradiotherapy TTFields (PORTRAIT)
19. Tumor Treating Fields (TTFields) Therapy to Manage Brain Metastases in Small Cell Lung Cancer
20. Study Of NOVOTTF-200A In Bevacizumab-Naive Subjects With Recurrent Grade III Malignant Astrocytoma
21. A Study of Tumor-Treating Fields (TTFields) in People With Lung Adenocarcinoma
22. Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma
23. TTFields and Radiosurgery of Recurrent Glioblastoma +/- 18F-Fluoro-Ethyl-Thyrosine (TaRRGET)
24. Improving Tumor Treating Fields Treatment for Brain Cancer Patients With Skullremodeling Surgery (Neurosurgery) (OptimalTTF-2)
25. Radiosurgery Plus NovoTTF-200A for Metastatic Small Cell Lung Cancer to the Brain (RAD 1704)
26. Single Arm Trial of Tumor-Treating Fields in Combination With Nivolumab and Ipilimumab in Metastatic Uveal Melanoma
27. Trial of Combination Tumor Treating Fields (TTF; Optune), Nivolumab Plus/Minus Ipilimumab for Recurrent Glioblastoma
28. NovoTTF-200A and Temozolomide Chemoradiation for Newly Diagnosed Glioblastoma
29. A Phase II Study of Optune (NovoTTF) in Combination With Bevacizumab (BEV) and Temozolomide (TMZ) in Patients With Newly Diagnosed Unresectable Glioblastoma (GBM)
30. NovoTTF Therapy in Treating Patients With Recurrent Glioblastoma Multiforme
31. TTFields and Pulsed Bevacizumab for Recurrent Glioblastoma
32. Optune Device - TT Field Plus Nivolumab and Ipilimumab for Melanoma With Brain Metastasis
33. Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
34. Optune(NOVOTTF-100A)+ Bevacizumab+ Hypofractionated Stereotactic Irradiation Bevacizumab-Naive Recurrent Glioblastoma (GCC 1344)
35. FORWARD Optune and Adjuvant TMZ in Grade II/III Astrocytoma (FORWARD)
36. Quality of Life of Patients With Glioblastoma (GBM) Treated With Tumor-Treating Fields (ACTION)
37. Optune® Plus Bevacizumab in Bevacizumab-Refractory Recurrent Glioblastoma
38. Anti-Cancer Effects of Carvedilol With Standard Treatment in Glioblastoma and Response of Peripheral Glioma Circulating Tumor Cells
39. Dielectric Properties of Matched Tissue Samples From Thoracic Malignancies and Corresponding Normal Tissues
40. NovoTTF-200A Device in Treating Patients With Newly Diagnosed High Risk Oligodendroglioma
41. Use of Optune TTF With Radiation as an Alternative for Elderly Patients With Primary CNS Lymphoma
42. Tumor-Treating Fields Therapy in Preventing Brain Tumors in Participants With Extensive-Stage Small Cell Lung Cancer
43. Study of NovoTTF-200A Alone and With Temozolomide in Patients With Low-Grade Gliomas
44. NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma
45. Enhancing Optune Therapy With Targeted Craniectomy
46. NovoTTF-100A With Bevacizumab and Carmustine in Treating Patients With Glioblastoma Multiforme in First Relapse
47. Brief report: High prevalence of somatic oncogenic driver alterations in non-small cell lung cancer patients with Li-Fraumeni Syndrome
48. Case report: Safety of Tumor Treating Fields therapy with an implantable cardiac pacemaker in a patient with glioblastoma.
49. Tumor Treating Fields (TTFields) induce homologous recombination deficiency in ovarian cancer cells, thus mitigating drug resistance.
50. Virtual multi-institutional tumor board: a strategy for personalized diagnoses and management of rare CNS tumors.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.